CAS: 117358-51-7; 1,3-Difluoro-5-Methylbenzene

相似化合物

461-97-2 151361-87-4 2927-34-6

上下游产品

CAS号141776-91-2 3,5-二氟苄溴 | CAS号1201597-22-9 2,6-二氟-4-甲基苯甲醛

3,5-二氟溴苄置于palladium-Carbon 氢气,Sodium Acetate体系中,化学反应生成3,5-二氟甲苯
参考文献:Isothiazole Derivatives Useful As Anticancer Agents
标题:Isothiazole Derivatives Useful As Anticancer Agents
摘要:本发明涉及式1化合物以及药用可接受的盐,前药和溶剂化物,其中x1,R1,R2和r3按本文定义.本发明还涉及包含上述化合物的药物组合物,以及通过施用上述化合物治疗哺乳动物过度增殖障碍的方法.

专利信息

专利号:US-2023212204-A1
优先权日:2020-01-16
标题:Reagents and their use for modular enantiodivergent synthesis of c-p bonds
发明人：XU DONGMIN; RIVAS-BASCÓN NAZARET; KNOUSE KYLE W; PADIAL NATALIA; ZHENG BIN; VANTOUROUT JULIEN; SCHMIDT MICHAEL; EASTGATE MARTIN D; BARAN PHI
权利人:BRISTOL MYERS SQUIBB CO; SCRIPPS RESEARCH INST
摘要:The disclosure describes chiral P(V)-based reagents and their uses for the modular, scalable, and stereospecific synthesis of chiral phosphines, phosphine oxides and particular oligonucleotides.

专利号:US-7615300-B2
优先权日:2005-08-30
标 题 :Development of novel proton-conductive polymers for proton exchange membrane fuel cell (PEMFC) technology
发明人：BAE CHULSUNG
权利人:REGENTS UNIVERSITY AND COMMUNI
摘要:New thermally and chemically stable sulfonic acid-containing polymers are synthesized via post-sulfonation of aromatic polymers. These new polymers provide unique benefits to proton exchange membrane fuel cell technology (“PEMFCâ€?). As a sulfonic acid moiety can be easily installed into an aromatic ring via electrophilic sulfonation, even in the presence of an electron-withdrawing substituent such as —F, rigid polymers consisting of aromatic rings at either the side chain or main chain can be prepared with a wide range of substituents and flexibility in properties. Novel synthetic procedures are provided for synthesis of the polymers.

专利号:WO-2021143617-A1
优先权日:2020-01-16
标题 :Cyclohexadiene oxime ether compound, synthesis method therefor and application thereof
发明人：DENG ZHAOXI; Hu Hewei; GUO SHAOXIONG; CEN JIN; TAN BIN; DU BINGBING; YANG LINA; LI JUNPEI
权利人:ZHENGZHOU INSTITUTE OF CHIRAL DRUGS RES CO LTD
摘要:The present invention provides a cyclohexadiene oxime ether compound having the following structural formula: (I) or (II) or (III); group R 1 and group R 3 are each selected from -H, an aliphatic substituent containing 1-6 carbon atoms, a halogenated aliphatic substituent, a cyano-substituted aliphatic substituent, amino or amide, phenyl, and a halogenated aromatic substituent or a cyano-substituted aromatic substituent; group R 2 is selected from -H, an aliphatic substituent containing 1-6 carbon atoms, a halogenated aliphatic substituent, a cyano-substituted aliphatic substituent, amino or amide, phenyl, a halogenated aromatic substituent, and a cyano-substituted aromatic substituent, a nitro-substituted aromatic substituent or a heterocyclic aromatic substituent; and the heterocyclic aromatic substituent is selected from (iv), (v) or (vi), wherein X is selected from -H, halogen, -CN, -NO 2 , and -CF 3 , -C(CF 3 ) 3 , and n is the number of substituents and is selected from 1, 2, and 3. The present invention also provides a preparation method for the above-mentioned cyclohexadiene oxime ether compound and an application thereof.

专利号:US-2005192265-A1
优先权日:2003-03-20
标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
发明人：THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

专利号:WO-2023177866-A1
优先权日:2022-03-18
标题 :Decarboxylative acetoxylation using mn(ii) or mn(iii) reagent for synthesis of 4'-acetoxy- nucleoside and use thereof for synthesis of corresponding 4'-(dimethoxyphosphoryl)methoxy- nucleotide

专利号:WO-2011028218-A1
优先权日:2009-09-02
标 题 :Process for triphosphate oligonucleotide synthesis
发明人：ZLATEV IVAN; MORVAN FRANCOIS; VASSEUR JEAN-JACQUES; DEBART FRANCOISE; MANOHARAN MUTHIAH
权利人:ALNYLAM PHARMACEUTICALS INC; CENTRE NAT RECH SCIENT; ZLATEV IVAN; MORVAN FRANCOIS; VASSEUR JEAN-JACQUES; DEBART FRANCOISE; MANOHARAN MUTHIAH
摘要:The present invention describes simple, efficient, and enzyme-free method of making oligonucleotides with 5'-triphosphate. This invention presents novel process for synthesizing triphosphate oligonucleotides using a diaryl phosphonate as reagent. The process of the present invention is amenable to large-scale, economic 5 '-triphosphate oligonucleotide synthesis.